LU76661A1 - - Google Patents

Info

Publication number
LU76661A1
LU76661A1 LU76661A LU76661A LU76661A1 LU 76661 A1 LU76661 A1 LU 76661A1 LU 76661 A LU76661 A LU 76661A LU 76661 A LU76661 A LU 76661A LU 76661 A1 LU76661 A1 LU 76661A1
Authority
LU
Luxembourg
Application number
LU76661A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU76661(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed filed Critical
Publication of LU76661A1 publication Critical patent/LU76661A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Cosmetics (AREA)
LU76661A 1976-01-30 1977-01-28 LU76661A1 (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (1)

Publication Number Publication Date
LU76661A1 true LU76661A1 (enrdf_load_html_response) 1977-08-03

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76661A LU76661A1 (enrdf_load_html_response) 1976-01-30 1977-01-28

Country Status (14)

Country Link
JP (1) JPS5294411A (enrdf_load_html_response)
AU (1) AU512593B2 (enrdf_load_html_response)
DE (1) DE2703119A1 (enrdf_load_html_response)
DK (2) DK154766C (enrdf_load_html_response)
ES (1) ES455478A1 (enrdf_load_html_response)
FI (1) FI770215A7 (enrdf_load_html_response)
FR (1) FR2339604A1 (enrdf_load_html_response)
IE (1) IE44760B1 (enrdf_load_html_response)
IL (1) IL51314A (enrdf_load_html_response)
LU (1) LU76661A1 (enrdf_load_html_response)
NL (1) NL185446C (enrdf_load_html_response)
NO (2) NO151860C (enrdf_load_html_response)
NZ (1) NZ183157A (enrdf_load_html_response)
SE (2) SE442268B (enrdf_load_html_response)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (enrdf_load_html_response) * 1987-03-05 1988-09-12
JPS63138229U (enrdf_load_html_response) * 1987-03-05 1988-09-12
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
CA2421976C (en) 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
WO1993011745A1 (en) * 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
ES2099415T3 (es) 1991-12-18 1997-05-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
CA2338680C (en) 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CN101677954A (zh) 2007-02-11 2010-03-24 Map药物公司 治疗性施用dhe用于快速减轻偏头痛而使副作用分布最小化的方法
CN116509836A (zh) * 2023-03-23 2023-08-01 中山万汉制药有限公司 色甘酸钠－季铵盐复合物及其制备方法与用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enrdf_load_html_response) * 1956-03-21 1900-01-01
BE556587A (enrdf_load_html_response) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK357588A (da) 1988-06-29
FI770215A7 (enrdf_load_html_response) 1977-07-31
SE8107278L (sv) 1981-12-04
DE2703119A1 (de) 1977-08-04
IL51314A0 (en) 1977-03-31
NO770286L (no) 1977-08-02
SE442268B (sv) 1985-12-16
NZ183157A (en) 1979-08-31
ES455478A1 (es) 1978-02-01
DK154766C (da) 1989-05-22
DK38077A (da) 1977-07-31
NO151860B (no) 1985-03-11
FR2339604B1 (enrdf_load_html_response) 1980-12-05
JPS5294411A (en) 1977-08-09
SE7700888L (sv) 1977-07-31
FR2339604A1 (fr) 1977-08-26
NL185446B (nl) 1989-11-16
DK357588D0 (da) 1988-06-29
IL51314A (en) 1980-03-31
DK156876B (da) 1989-10-16
IE44760B1 (en) 1982-03-24
SE442267B (sv) 1985-12-16
NO780183L (no) 1977-08-02
DK154766B (da) 1988-12-19
NO151860C (no) 1985-06-19
DE2703119C2 (enrdf_load_html_response) 1990-10-25
AU2162677A (en) 1978-08-03
DK156876C (da) 1990-03-12
AU512593B2 (en) 1980-10-16
NL7700911A (nl) 1977-08-02
NL185446C (nl) 1990-04-17
IE44760L (en) 1977-07-30
JPS6129929B2 (enrdf_load_html_response) 1986-07-10

Similar Documents

Publication Publication Date Title
FR2366544B1 (enrdf_load_html_response)
FR2339604B1 (enrdf_load_html_response)
FR2358970B1 (enrdf_load_html_response)
FR2364886B1 (enrdf_load_html_response)
FR2366387B1 (enrdf_load_html_response)
JPS5512750B2 (enrdf_load_html_response)
JPS5727155Y2 (enrdf_load_html_response)
JPS5633457Y2 (enrdf_load_html_response)
JPS5512718Y2 (enrdf_load_html_response)
FR2368703B1 (enrdf_load_html_response)
JPS563550Y2 (enrdf_load_html_response)
JPS55662B2 (enrdf_load_html_response)
JPS5346418U (enrdf_load_html_response)
CS178393B1 (enrdf_load_html_response)
JPS52171271U (enrdf_load_html_response)
JPS52146080U (enrdf_load_html_response)
JPS52143634U (enrdf_load_html_response)
JPS52123685U (enrdf_load_html_response)
JPS52154339U (enrdf_load_html_response)
JPS539055U (enrdf_load_html_response)
CH594276A5 (enrdf_load_html_response)
DD125161A1 (enrdf_load_html_response)
CH601750A5 (enrdf_load_html_response)
BG23361A1 (enrdf_load_html_response)
BG23315A1 (enrdf_load_html_response)